-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Jefferies Downgrades Nuvation Bio to Hold, Lowers Price Target to $2

Benzinga · 01/06/2023 05:26
Jefferies analyst Michael Yee downgrades Nuvation Bio (NYSE:NUVB) from Buy to Hold and lowers the price target from $5 to $2.